US 10640535
Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
granted A61KA61K38/00A61K39/0011
Quick answer
US patent 10640535 (Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies) held by The Board of Regents of the University of Oklahoma expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K38/00, A61K39/0011, A61P, A61P35/00